9
total announcements
533138.BO · 15 min delayed
Astec Lifesciences Ltd
Astec Lifesciences Ltd has published unaudited financial results for the quarter ended June 30, 2026, in newspapers as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Astec Lifesciences Ltd
Astec Lifesciences Ltd held its 32nd Annual General Meeting on July 31, 2026, where the shareholders approved the financial statements for the year ended March 31, 2026, and re-appointed Ashok V. Hiremath as a director. The meeting was conducted through video conferencing, and the results of the voting will be declared within two working days.
Astec Lifesciences Ltd
Astec Lifesciences Ltd has held its 32nd Annual General Meeting (AGM) on July 31, 2026, where the shareholders approved the financial statements for the year ended March 31, 2026, and re-appointed Ashok V. Hiremath as a director.
Astec Lifesciences Ltd
Astec Lifesciences Ltd held its 32nd Annual General Meeting (AGM) on July 31, 2026, through video conferencing. The meeting was convened and held as per the Notice of the AGM dated April 27, 2026. The Company Secretary welcomed the shareholders and briefed them on the procedural and technical aspects of the AGM. The Directors, Statutory Auditors, and Secretarial Auditors attended the meeting through video conference. The Chairperson delivered his speech to the shareholders, informing them that the Company had provided an electronic voting facility through remote e-voting. The results of the voting will be declared within 2 working days of the AGM conclusion.
Astec Lifesciences Ltd
Astec Lifesciences Ltd has held its 32nd Annual General Meeting (AGM) on July 31, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and Mr. Ashok V. Hiremath was re-appointed as a director.
Astec Lifesciences Ltd
Astec LifeSciences Limited has announced its unaudited financial results for the quarter ended 30th June, 2026, with a consolidated total income of ₹84.3 crore, a 8% decrease from ₹91.6 crore in the same period last year. The company reported an EBITDA of ₹0.1 crore, a significant improvement from an EBITDA loss of ₹10.5 crore in the same period last year. The company's revenue from Enterprise Products grew 42% YoY to ₹51.8 crore, driven by higher volumes and improved realizations.
Astec Lifesciences Ltd
Astec Lifesciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a loss of Rs. 1,873.82 lakhs before tax and Rs. 1,870.73 lakhs after tax.
Astec Lifesciences Ltd
Astec Lifesciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a loss before tax of Rs. 1,873.82 lakhs and a loss after tax of Rs. 1,870.73 lakhs. The company's revenue from operations was Rs. 8,356.43 lakhs, and its total income was Rs. 8,429.17 lakhs. The board of directors has approved the unaudited financial results, and the statutory auditors have issued a limited review report with an unmodified opinion.
Astec Lifesciences Ltd
Astec Lifesciences Ltd has scheduled a Board Meeting on 31/07/2026 to consider and approve Standalone and Consolidated Unaudited Financial Results for the Quarter ended 30/06/2026.